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Background-—Uninephrectomy (UNX) is performed for various reasons, including kidney cancer or donation. Kidneys being the
main site of L-arginine production in the body, we tested whether UNX mediated kidney mass reduction impacts L-arginine
metabolism and thereby nitric oxide production and blood pressure regulation in mice.
Methods and Results-—In a ﬁrst series of experiments, we observed a signiﬁcant increase in arterial blood pressure 8 days post-
UNX in female and not in male mice. Further experimental series were performed in female mice, and the blood pressure increase
was conﬁrmed by telemetry. L-citrulline, that is used in the kidney to produce L-arginine, was elevated post-UNX as was also
asymmetric dimethylarginine, an inhibitor of nitric oxide synthase that competes with L-arginine and is a marker for renal failure.
Interestingly, the UNX-induced blood pressure increase was prevented by supplementation of the diet with 5% of the L-arginine
precursor, L-citrulline. Because L-arginine is metabolized in the kidney and other peripheral tissues by arginase-2, we tested
whether the lack of this metabolic pathway also compensates for decreased L-arginine production in the kidney and/or for local
nitric oxide synthase inhibition and consecutive blood pressure increase. Indeed, upon uninephrectomy, arginase-2 knockout mice
(Arg-2/) neither displayed an increase in asymmetric dimethylarginine and L-citrulline plasma levels nor a signiﬁcant increase in
blood pressure.
Conclusions-—UNX leads to a small increase in blood pressure that is prevented by L-citrulline supplementation or arginase
deﬁciency, 2 measures that appear to compensate for the impact of kidney mass reduction on L-arginine metabolism. ( J Am Heart
Assoc. 2018;7:e008025. DOI: 10.1161/JAHA.117.008025.)
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R emoval of 1 kidney (uninephrectomy; UNX) causes ahypertrophy of the remnant kidney without an increase
in the number of nephrons given that in humans nephroge-
nesis ceases at birth.1 Until very recently, not much was
known about what triggers this compensatory enlargement of
the remaining kidney post-UNX and regulates its extent.
Recently, the laboratory of R.C. Harris2 has shown that the
observed increase in blood ﬂow through the remnant kidney
and the consecutively increased amino acid delivery activates
a class III phosphatidylinositol-3 kinase that induces mech-
anistic target of rapamycin complex 1 (mTORC1)/p70 ribo-
somal protein kinase 1 (S6K1) signaling and thereby the
compensatory increase in kidney size. However, the compen-
satory growth of the remnant kidney amounts to 20%3,4
such that not only the ﬁltration and transport capacities, but
also the metabolic functions are presumably not fully
compensated.
L-arginine is 1 of the 20 naturally occurring amino acids
and is categorized as a conditionally essential amino acid in
humans. It plays an important role, acting as a precursor for a
variety of physiologically important substances. For L-arginine
homeostasis, the proximal tubule of the kidney not only fulﬁlls
the typical epithelial transport function consisting in amino
acid reabsorption from the primary urine, but also plays a
central role in its metabolism. In particular, the majority of
L-arginine is produced in the kidney from circulating
L-citrulline. Indeed, when L-arginine is absorbed from food, it
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is, to a large extent, metabolized to L-citrulline in the
intestine.5 This metabolite of arginine then escapes further
modiﬁcations when passing through the liver, unlike L-arginine
that is efﬁciently metabolized there by arginase-1 into urea
and L-ornithine that, in turn, may be further metabolized for
producing polyamines or L-proline. Circulating L-citrulline, in
contrast, is, to a large extent, metabolized back to L-arginine,
mostly in the kidney.6 The other major metabolic pathway
using L-arginine as substrate is the production of nitric oxide
(NO) by the various NO synthases. Whereas for the function of
NO synthase the availability of L-arginine has been shown to
be limiting, methylated forms of L-arginine, in contrast, inhibit
NO synthesis.7,8 Methylation of protein arginines, namely
monomethylation to NG monomethyl-L-arginine and dimethy-
lation to the symmetric or asymmetric NGNGdimethyl-L-
arginines (symmetric dimethylarginine or asymmetric
dimethylarginine [ADMA]) are post-translational modiﬁcations
that play an important role, for instance, in proteins involved
in transcriptional regulation, RNA metabolism, and signal
transduction. Breakdown of these methylated proteins
releases the free methylated arginines of which both ADMA
and NG monomethyl-L-arginine can inhibit all isoforms of NO
synthase.9 These competitive inhibitors are found to be
elevated and of particular consequence in chronic kidney
disease.10,11 Furthermore, population studies have shown
that symmetric dimethylarginine levels correlate with
cardiovascular mortality.12 Therefore, a therapy used some-
times in patients suffering from chronic kidney disease or
cardiovascular disease is to increase the bioavailability of
L-arginine. This may be done by administering L-citrulline,
because this L-arginine precursor escapes modiﬁcations in the
intestine or the liver and can be processed in the kidneys to
produce L-arginine. This increased L-arginine may then be
used for NO production, in particular by endothelial NO
synthase (NOS3), and thereby it is expected to contribute to
the alleviation of high blood pressure.13–15
Another enzyme that plays a role in L-arginine metabolism,
and thus its availability, is arginase, which catalyzes the
breakdown of L-arginine to urea and L-ornithine. Arginase is
present in 2 isoforms. Arginase-1 is cytosolic and predomi-
nantly expressed in the liver. Its dysfunction leads to arginine-
mia, which is characterized by hyperammonemia.16 Arginase-2,
on the other hand, is apparently mostly mitochondrial and
expressed in non-hepatic tissues, particularly in the kidney.17
The physiological role of this enzyme continues to be poorly
understood, although to better understand its role, arginase-2
knockout (Arg-2/) mice were generated more than a decade
ago.18 These mice were viable and no major differences were
detected compared with wild-type mice. Nonetheless, plasma
L-arginine levels were elevated, which indicates a role of
arginase-2 in systemic L-arginine homeostasis.
Various studies in patients and with animal models have
indicated that UNX as performed in kidney donors may lead to
changes in different parameters, including, next to glomerular
ﬁltration rate, also blood pressure.19–21 UNX in adult mice
mimics the situation of living kidney donation of humans, a
condition that becomes increasingly frequent because of the
lack of sufﬁcient deceased donors and increased demand.
In this study, we tested whether the decrease in renal mass
consecutive to UNX inﬂuenced renal L-arginine production and
transport and thereby also the control of blood pressure for
which L-arginine-derived NO plays an important role. Because a
ﬁrst series of experiments had revealed, only in female mice, a
clear effect of UNX on blood pressure, subsequent experiments
were performed only with females. Two strategies were then
used to partially compensate the effects of a presumably
decreased renal L-arginine production post-UNX, supplemen-
tation with L-citrulline, and the use of Arg-2/ mice.
Materials and Methods
The authors declare that all supporting data are available
within the article and its online supplementary ﬁle.
Animals
Experiments were performed in C57/BL6mice purchased from
Charles River Laboratories (Munich, Germany) and Arg-2/
Clinical Perspective
What Is New?
• Uninephrectomy (UNX) causes in female mice an increase in
plasma asymmetric dimethyl arginine, L-citrulline, and blood
pressure.
• This UNX-induced blood pressure increase is attenuated by
L-citrulline supplementation and in arginase-2 deﬁcient
(Arg-2/) mice.
What Are the Clinical Implications?
• Experiments performed in mice suggest that UNX-mediated
kidney mass reduction interferes with L-arginine metabolism
and thereby with blood pressure regulation, in particular in
females.
• Asymmetric dimethyl arginine is suggested to mediate UNX-
induced blood pressure increase by competing with L-arginine
for nitric oxide synthesis.
• Dietary supplementation with the L-arginine precursor, L-
citrulline, or deletion of L-arginine metabolizing enzyme
arginase-2 prevents blood pressure dysregulation in this
murine model of live kidney donation.
• Future studies in animal models and humans are required to
clarify the apparent sex difference regarding effects of UNX
on L-arginine metabolism and blood pressure control.
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mice,18 which have been back-crossed into the same back-
ground.22 All procedures for mice handling and experimental
interventions were performed in accord with Swiss Animal
Welfare laws and approved by the Cantonal Veterinary Ofﬁce,
Z€urich. Before the start of experimentation, animals were
allowed to acclimatize for a 2-week period. During the
experiments, animals had access to food and water ad libitum.
Between 7 and 20 animals were included in each experimental
group (see Results). The normal diet contained 18% protein,
whereas for the L-citrulline supplementation experiments, the
normal diet was supplemented with 5% (w/w) of L-citrulline. For
the L-citrulline supplementation study, animals were placed on
the L-citrulline diet for 8 days and then on the normal diet for
8 days presurgery. Post-UNX, animals continued on the normal
diet and were again switched to the L-citrulline diet for 8 days.
Blood pressure was measured on the L-citrulline diet on days
8 and 8 and on the normal diet on days 1 and 8.
Uninephrectomy
Mice (10–12 weeks) were randomly assigned to undergo UNX
or sham surgery. For the surgery, mice were brieﬂy
anesthetized with 3% isoﬂurane and then maintained with
1% to 2% isoﬂurane with oxygen as the carrier. Brieﬂy, the
region undergoing surgery was shaved and an incision was
made on the left side. The adrenal was carefully separated
from the upper pole of the kidney before ligating the renal
pedicle. The left kidney was then removed and the peritoneum
and the skin sutured. For sham surgeries, the same process
was followed and the kidneys were exposed but not ablated.
Metabolic Cage Measurements
Mice were placed individually in metabolic cages (Techniplast,
Buguggiate, Italy) with food and drinking water available
ad libitum ﬁrst for 8 hours on 3 consecutive days for
adaptation. Then, after 1 day in a normal cage, they were
placed again in the metabolic cages for a 24-hour collection
period of feces and urine (under mineral oil), during which
food and water consumption and body weight were measured.
At the end of the 24-hour period, after removing access to
food for 30 minutes, blood was collected from the tail vein of
mice and plasma was prepared (5000 RCF, 5 minutes, 4°C)
and frozen for further analysis.
Blood Pressure Measurement With Tail Cuff
Systolic blood pressure was measured using a noninvasive tail-
cuff method (BP2000; Visitech Systems, Apex, NC) in
restrained mice as described previously.23 Mice were adapted
for 5 days before the start of the experiment. This adaptation
has been shown to reduce stress-related side effects.23 In each
case, 10 preliminary measurements were conducted, followed
by 15 actual measurements. Averages of systolic blood
pressure (SBP) measurements having SDs less than 10 mm Hg
were considered for further analysis. Measurements were
taken 2 to 3 hours after the beginning of the light phase.
Blood Pressure Measurement by Telemetry
Radiotelemetry is considered to be the gold standard for
measuring blood pressure in rodents, initially in rats and then
also in mice.24 Manufacturer instructions were followed, and the
transmitter was implanted as previously described.25 Brieﬂy,
mice were anesthetized with the aid of isoﬂurane and implanted
with a PA-C-10 transmitter (Data Sciences International [DSI], St.
Paul, MN). The catheter was implanted in the carotid artery
taking care to place the pressure-sensitive tip in the aortic arch.
Mice were given analgesic for 3 days postsurgery alongwith pre-
emptive analgesic. One week after telemetry implantation, a test
measurement was conducted to ensure that animals had
recovered and that the circadian clock was back to normal.
UNX was performed 8 days after these measurements.
Measurements were recorded with Dataquest ART (version
3.1) and RespiRate (DSI). Recordings were made for a 3-day
period every week. Recordings were continuously taken for
30 seconds every 5 minutes during this time. Systolic,
diastolic, and mean blood pressure, heart beat, and activity
were analyzed separately for the light versus dark phases.
Plasma Amino Acid Measurements
Amino acids were measured after extraction with methanol
without derivatization (Neobase Kit; Perkin Elmer, Turku, Finland)
on an XEVO-TQD tandem mass spectrometer (Waters, Milford,
MA). Brieﬂy, 4 lL of plasma or urine were spotted onto
prepunched plain ﬁlter paper (Ahlstom 226) in 96-well plain
uncoated microtiter plates. Amino acids were extracted with
100 lL of methanolic extraction solution containing stable
isotope-labeled internal standards by shaking for 45 minutes at
45°C. Twenty microliters of extract were then injected with a
ﬂow rate of 10 lL/min directly into the tandem mass
spectrometer and measured afterward in multiple reaction
monitoring mode. In addition to the amino acids, which are
incorporated in theNeobase kit, ADMAwas added to themultiple
reaction monitoring experiment with the following settings:
parent ion, 203.1 Da; daughter ion, 46.1 Da; dwell time,
0.05 seconds; cone voltage, 26 V; and collision energy, 37 eV.
Immunoﬂuorescence Staining and Confocal
Microscopy
Rabbit antibody against arginase-2 (sc-20151) was from
Santa Cruz Technology Inc (Nunningen, Switzerland); Alexa
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Fluor 488–conjugated goat antirabbit IgG (H+L) secondary
antibody (A-11008) was from Invitrogen/Thermo Fisher
Scientiﬁc (Waltham, MA).
Kidneys from wild-type and Arg-2/ mice were isolated
and ﬁxed with 3.7% PFA and embedded in parafﬁn. After
deparafﬁnization in xylene (3 times, 5 minutes for each),
hydration in ethanol (twice in 100% ethanol, twice in 95%
ethanol, and once in 80%, 70%, 50% ethanol for 5 minutes,
sequentially), heat-induced epitope retrieval in Tris-EDTA
buffer (10 mmol of Tris Base, 1 mmol/L of EDTA, and
0.05% Tween-20; pH 9.0) was performed in a pressure cooker
for 3 minutes to unmask antigens present in renal tissue.
Tissue sections (5 lm) were then blocked with 10% BSA in
PBS for 1 hour and followed by an incubation with primary
antibodies (arginase-2 1:100, B0AT3 1:200) overnight at 4°C
and subsequently exposed to ﬂuorescence-labeled secondary
antibodies (1:400) at room temperature for 2 hours, respec-
tively. Immunoﬂuorescence signals were visualized under
Leica’s DIM6000 confocal microscope (Leica Microsystems,
Wetzlar, Germany).
Statistical Analysis
GraphPad Prism software (version 6; GraphPad Software Inc,
San Diego, CA) was used to perform statistical analysis.
Differences between groups were determined by Student t
test for 2 groups (paired in case the same animal was being
followed over time) or 1-way repeated-measures ANOVA for
≥3 groups with a Dunnett post-hoc test versus a control
group. Values are presented as meansSEM and were
considered different when P<0.05.
Results
UNX Leads to Increased Blood Pressure in
Female Mice
In a ﬁrst series of experiments, wild-type C57BL6 mice were
subjected to left UNX or sham surgery as described in
Materials and Methods section, and their blood pressure was
measured by the tail-cuff technique pre- and postsurgery.
Both female (Figure 1A) and male (Figure 1B) UNX mice
showed an increase in weight of the remnant right kidney.
UNX provoked an increase in SBP that was signiﬁcant only in
female (Figure 1C) but not in male mice (Figure 1D). There-
fore, and also because ADMA was increased only in females
(Figure S1 and below), further experiments were performed
with female mice. SBP in female mice presurgery and 8, 10,
and 30 days postsurgery was 122.22.1, 131.62.5,
134.92.5, and 135.62.6 mm Hg, respectively (Figure 1E).
Importantly, sham-operated animals displayed no signiﬁcant
change in mean SBP during this period (1230.5 mm Hg).
To verify the results obtained by the tail-cuff technique,
blood pressure measurements were performed in female mice
using telemetry. Similarly to the observation made with the
tail-cuff technique, SBP was found to be increased post-UNX
in female mice, actually both during the inactive and the
active phase (light/dark cycle). Representative traces from 1
mouse (8 days pre-UNX and 10 days post-UNX) are shown in
Figure S2. Speciﬁcally, mean SBP was increased within
30 days postsurgery from 110.20.9 to 119.41.8 mm Hg
and from 125.61.3 to 134.81.6 mm Hg during the
inactive and active phases, respectively (Figure 1F). Similarly,
diastolic pressure was increased from 81.50.8 to
91.50.9 mm Hg and from 94.60.8 to 103.21.8 mm Hg
during the inactive and active phases, respectively.
Impact of UNX on Plasma Amino Acid Levels
Plasma levels of amino acids before and at various points
after surgery were measured from wild-type mice subjected to
UNX and from control-operated mice (sham) to identify
potential changes attributed to UNX and not to a general
effect of the surgery, anesthesia, analgesia, or environmental
factors, etc. Whereas surgery appeared to impact onto the
level of several of the measured amino acids and metabolites,
UNX per se did not modify the level of any of the measured
proteinogenic amino acids (Figure S3). In contrast, the level of
ADMA and that of the L-arginine precursor, L-citrulline, were
both signiﬁcantly altered by UNX (Figure 2A and 2B).
However, the level of arginine itself and of the other tested
amino acids involved in its metabolism, such as L-ornithine
and the methylated L-arginines NG monomethyl-L-arginine and
symmetric dimethylarginine, was not differentially affected by
UNX versus sham operation (Figure S3).
Citrulline Supplementation Largely Prevents
Blood Pressure Increase Post-UNX
L-citrulline has been used for therapeutic purposes to increase
the availability of L-arginine because it is not metabolized in
the liver and can be used by the kidney to produce
L-arginine.26 We tested the effect of this L-arginine precursor
on blood pressure by ﬁrst placing kidney-intact mice on a diet
supplemented with 5% L-citrulline (w/w) and switched then to
a normal diet. Measurements of SBP performed by the tail-
cuff method revealed that the L-citrulline-supplemented diet
and the switch back to control diet did not impact on blood
pressure of kidney-intact mice (Figure 3). Half of these
animals were then subjected to UNX and the other half to
sham surgery. Tail-cuff blood pressure was again recorded
when mice were maintained ﬁrst on control- and then on
L-citrulline-supplemented diet. As expected, under normal
diet, UNX mice showed an increase in SBP compared with
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Figure 1. Effect of uninephrectomy (UNX) on remnant kidney weight and systolic blood pressure. A and B, UNX
caused an increase in weight of the remnant right kidney in both male and female mice (white bars) compared with pre-
UNX value (left kidney) and to the right kidney of sham-operated mice (gray bars; n=10). ***P<0.001. C and D,
Measurements performed by the tail-cuff technique at an age of 10 to 12 weeks showed (C) in female mice submitted to
UNX (white bars; n=10–20) an increase in systolic blood pressure and no change in sham-operated mice (gray bars;
n=10–20). *P<0.05 compared with pre-UNX; #P<0.05 compared with sham. D, Male mice submitted to UNX (white bars)
as sham-operated ones (gray bars; each n=10) showed no blood pressure change. E, Female mice submitted to UNX
(white bars) continued to show an increase in systolic blood pressure up to 30 days post-UNX when compared with
sham-operated animals (gray bars) or their values pre-UNX. *P<0.05, **P<0.01 compared with pre-UNX; #P<0.05,
##P<0.01 compared with sham. F, Telemetric blood pressure measurements performed in 10- to 12-week-old female
mice submitted to UNX 2 weeks after device implantation conﬁrmed the post-UNX increase in blood pressure that was
observed during both the inactive light and active dark phases (n=7–10). *P<0.05, **P<0.01, comparing before and
after surgery.
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sham-operated mice. When the diet was switched again to
L-citrulline supplementation, SBP decreased nonsigniﬁcantly
in UNX mice, however reaching the same level as in sham-
operated mice. From this experiment, we conclude that
L-citrulline supplementation prevents UNX-induced blood
pressure increase.
Arg/ Mice Do Not Show an Increase in Blood
Pressure Post-UNX
We hypothesized that in the absence of arginase-2, more
L-arginine might be available for NO synthesis and thus the
impact of UNX on blood pressure would be reduced. Using
arginase-2 antibodies, we ﬁrst conﬁrmed that arginase-2 is
indeed expressed in the kidney, and show that this is mostly
in the straight part of the proximal tubule cells as conﬁrmed
by the expression of the luminal B0AT3 amino acid
transporter in the same cells.27,28 As expected, arginase-2
expression is absent in Arg-2/ mice (Figure 4).
We then tested the impact of UNX on blood pressure in
Arg-2/ mice by telemetry. Unlike wild-type mice, they did
not show a signiﬁcant increase in SBP after UNX surgery in
either the inactive or active phase (Figure 5A and 5B). During
the inactive phase, SBP of unoperated Arg-2/ mice
appeared to be more elevated than that of wild-type mice
(compare with Figure 1F), in accord with a previous report.14
Importantly, however, this value (119.91.7 presurgery)
remained unchanged upon UNX (119.71.4 mm Hg 20 days
postsurgery; Figure 5A). During the active phase, their SBP
nonsigniﬁcantly increased from 126.53.0 presurgery to
132.31.5 mm Hg 20 days postsurgery (Figure 5B). Dias-
tolic pressure was unchanged from 112.31.5 to
112.41.6 mm Hg and nonsigniﬁcantly increased from
114.71.8 to 119.31.8 mm Hg during the inactive and
active phases, respectively. Also, plasma levels of ADMA and
L-citrulline, which were increased in wild-type animals,
remained unchanged in Arg-2/ mice post-UNX surgery
(Figure 5C and 5D), suggesting that both the alterations of
arginine metabolism and of blood pressure were prevented by
the lack of arginase-2.
Discussion
It has been known for decades that renal mass reduction by
UNX induces a compensatory hypertrophy of the remnant
Figure 2. Effect of uninephrectomy (UNX) on plasma asymmet-
ric dimethylarginine (ADMA) and L-citrulline concentrations.
UNX animals (white bars) showed (A) an increase in plasma
ADMA and (B) L-citrulline levels postsurgery. *P<0.05, **P<0.01,
***P<0.001 comparing UNX before and after surgery; #P<0.05,
##P<0.01 comparing with sham (gray bars). n=7 to 28 animals per
group.
Figure 3. Effect of 5% L-citrulline supplemented diet (CD) on
uninephrectomy (UNX)-induced systolic blood pressure changes.
On a normal diet post-UNX (white bars), animals showed an
elevated systolic blood pressure as in previous cases (measured
by the tail-cuff method), but when they were shifted to an
L-citrulline supplemented diet, this elevation in blood pressure
was no longer observed, indicating that L-citrulline supplementa-
tion prevents the blood pressure increase observed post-UNX.
*P<0.05 comparing UNX before and after surgery; #P<0.05
comparing to corresponding sham (gray bars). n=9 animals per
group.
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kidney. However, only in recent years have actual mecha-
nisms involved in regulation of this compensatory growth
been reported (Chen et al,2 references therein and Introduc-
tion). Also, UNX is increasingly often performed in humans for
kidney donation because of the demand linked to the
continuously high incidence of end-stage renal disease, lack
of sufﬁcient deceased donor kidneys, and comparatively
better outcome of transplantation with kidneys from live
donors.29,30 In view of the fact that L-arginine production from
L-citrulline takes place primarily in the proximal tubule of the
kidney,31 we hypothesized that a decrease in renal mass
would have an adverse effect on L-arginine homeostasis and,
consequently, on blood pressure regulation by decreasing
substrate availability for NO synthesis.
Interestingly, we observed, in our initial experiments, that
UNX induced a signiﬁcant increase in blood pressure in
female mice, but not in male mice. This sex difference is per
se an interesting observation that we, however, did not follow,
focusing for the remainder of the study on female mice.
Actually, it is interesting to note that published studies with
precise blood pressure measurements pre- and post-UNX
were as yet performed, to our knowledge, in male mice (see,
eg, Crowley et al32,33). We observed that compensatory
kidney growth was possibly more effective in males than
females (Figure 1A and 1B, difference not signiﬁcant), but
whether this might impact onto the differential blood pressure
response observed in this study is not clear.34,35 Actually, we
are not aware of previous studies indicating that kidney mass
reduction leads to a sex-speciﬁc blood pressure increase.
Concerning human kidney donors, addressing the question of
whether UNX impacts on blood pressure control has been
debated in particular because of the lack of appropriate
control groups. A recent study on the Swiss Organ Living-
Donor Health Registry comparing the occurrence of hyper-
tension with appropriately corrected estimates from the
Framingham hypertension risk score suggested that kidney
donation increases the risk of hypertension by 3.6% after
1 year (Thiel et al36 and references therein), This study did,
however, not mention a possible sex difference in the
occurrence of hypertension. Also, the question of sex
differences in renal transplant outcomes has been debated
and addressed recently in a very large retrospective study on
the Scientiﬁc Registry of Transplant Recipients database.
Interestingly, this study revealed an increased number of graft
failure in (young) female versus male recipients. However,
there is as yet no explanation for this sex difference, and the
question of kidney growth and blood pressure was not
addressed in this study.37
The endothelial dysfunction observed in chronic renal
failure is often considered to be resulting from a decrease in
L-arginine bioavailability for NO synthesis that is related to an
increase in competing L-arginine analogues.38,39 Indeed,
increased ADMA levels might explain the arginine paradox,
namely the observation that administering acutely L-arginine
Figure 4. Immunoﬂuorescence imaging of arginase-2 and B0AT3. Confocal immunoﬂuorescence
staining on consecutive kidney sections of wildtype and Arg-2/ mice show Arg-2 (green) staining in
cells of wild-type (WT) mice positive for the luminal proximal tubule amino acid transporter B0AT3
(Slc6a18) highly expressed in the S3 straight segments of the proximal tubule. Arg-II indicates
arginase-2.
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(or L-citrulline) to patients with cardiovascular and renal
diseases increases their NO production and thereby improves
their endothelial function, although plasma levels of L-arginine
are similar to those of healthy individuals and much higher
than the Km of NO synthases.40,41 However, ADMA levels
tend to be signiﬁcantly higher in these patients compared
with healthy individuals, and this modiﬁed L-arginine functions
as a competitive inhibitor of L-arginine for NO synthesis.7,42
Because our experiments showed an unchanged L-arginine
concentration in plasma, we investigated whether it may be a
decrease of its relative availability for NO synthesis attributed
to the competition by ADMA that interferes with blood
pressure control after kidney mass reduction. To potentially
increase the local intracellular availability of L-arginine for NO
synthesis, we tested the effect of dietary L-citrulline, the
precursor of kidney-produced L-arginine that is not catabo-
lized upon passage through the liver.43 Despite the fact that
L-citrulline was actually already increased, to some extent,
post-UNX ( +30%), this additional dietary L-citrulline
prevented, to a large extent, the UNX-induced increase in
blood pressure, supporting this hypothesis.
Yet another approach to testing the role of L-arginine
availability on the observed UNX-induced blood pressure
increase was to test the impact of UNX in Arg-2/ mice that
lack an important intracellular pathway consuming L-arginine.
Arg-2/ mice indeed did not develop high blood pressure
post-UNX, again supporting the hypothesis that the local
availability of L-arginine is a limiting factor for NO synthesis
and thus blood pressure control. Taken together, the
L-citrulline diet and Arg-2/ experiments support our
hypothesis that renal mass reduction leads to an elevated
blood pressure that is mediated by the defective bioavailabil-
ity of L-arginine for NO synthesis. Based on the plasma amino
acid and dimethylated arginine values measured in UNX mice,
this defective bioavailability of L-arginine does not appear to
be attributed primarily to a decrease in L-arginine concentra-
tion related to the kidney mass reduction. It is rather the
increased level of ADMA that is suggested to play a central
role in mediating the observed blood pressure increase. This
ADMA increase may be attributed, to a large extent, to a
decreased availability of its metabolizing enzyme, dimethy-
larginine dimethylaminohydrolase, whose overall amount is
presumably altered by renal mass reduction. Thus, in UNX
female mice, it is presumably the increase in ADMA that
mediates the observed increase in blood pressure by
interfering with endothelial NO synthesis.
Figure 5. No uninephrectomy (UNX)-induced changes in blood pressure and plasma asymmetric
dimethylarginine (ADMA) and L-citrulline levels in arginase-2 knockout (Arg-2/) mice. Arg-2/ mice
displayed no signiﬁcant increase in blood pressure post-UNX (dashed bars with white background) both in
the inactive (A) and in active (B) phases as measured by telemetry. They showed also no changes in plasma
levels of ADMA (C) and L-citrulline (D) compared with sham-operated mice (dashed bars with gray
background). n=9 animals per group.
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Conclusions and Perspectives
Taken together, this study links metabolic effects of moderate
kidney mass reduction, in particular as regards L-arginine
production from L-citrulline and metabolism by arginase-2 as
well as ADMA metabolism, to blood pressure control. The
present experiments performed in female mice suggest
possible interventions such as dietary supplementation with
the L-arginine precursor, L-citrulline, and the inhibition of
arginase-2 function as means of preventing blood pressure
dysregulation in cases of kidney mass reduction such as upon
live kidney donation. Future experiments will need to clarify
the apparent sex difference regarding effects of nephrectomy
on L-arginine metabolism and blood pressure control both in
animal models and humans.
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